{
  "id": 1668,
  "text": "30 (95%CI= 0.16-0.54)</td></tr><tr><td>Duenas-Gonzalez et al.1435</td><td>2011</td><td>CCRT (cisplatin)</td><td>CCRT (cisplatin + gemcitabine)</td><td></td></tr><tr><td>Coronel et al.1431</td><td>2013</td><td>CCRT (cisplatin)</td><td>CCRT (vinorelbine)</td><td>OR = 0.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 30 (95%CI= 0.16-0.54)</td></tr><tr><td>Duenas-Gonzalez et al.1435</td><td>2011</td><td>CCRT (cisplatin)</td><td>CCRT (cisplatin + gemcitabine)</td><td></td></tr><tr><td>Coronel et al.1431</td><td>2013</td><td>CCRT (cisplatin)</td><td>CCRT (vinorelbine)</td><td>OR = 0.\n\n<question>: ",
  "ChatGPT_response_0": "基于研究显示的结果，CCRT使用顺铂与紫杉醇治疗方案之间存在一定的关联性。然而，具体的关联程度需要考虑到95%的置信区间为0.16-0.54。这表明在CCRT治疗中，使用顺铂和紫杉醇可能会对结果产生不同程度的影响。在制定治疗方案时，医生会根据患者的具体情况和疾病特点来选择适合的药物，以获得最佳的治疗效果。",
  "query": "这项研究中CCRT（顺铂）与CCRT（紫杉醇）治疗方案的关联性如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这项研究中CCRT（顺铂）与CCRT（紫杉醇）治疗方案的关联性如何？\n\n<reference text>: 30 (95%CI= 0.16-0.54)</td></tr><tr><td>Duenas-Gonzalez et al.1435</td><td>2011</td><td>CCRT (cisplatin)</td><td>CCRT (cisplatin + gemcitabine)</td><td></td></tr><tr><td>Coronel et al.1431</td><td>2013</td><td>CCRT (cisplatin)</td><td>CCRT (vinorelbine)</td><td>OR = 0.\n\n<reply>: ",
  "response": "基于研究显示的结果，CCRT使用顺铂与紫杉醇治疗方案之间存在一定的关联性。然而，具体的关联程度需要考虑到95%的置信区间为0.16-0.54。这表明在CCRT治疗中，使用顺铂和紫杉醇可能会对结果产生不同程度的影响。在制定治疗方案时，医生会根据患者的具体情况和疾病特点来选择适合的药物，以获得最佳的治疗效果。"
}